CD83-overexpressing CAR-T cells initially showed less efficient control of tumor growth, which is consistent with the in vitro data that ectopic expression of CD83 attenuated the production of cytolytic molecules (Fig. 5j, k). The gene discussed is CD83; the disease is neoplasm.